EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access

Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis

Louise M Henderson, Weiwei Zhu, Tracy Onega, Karla Kerlikowske, Diana L Miglioretti, Erin J Aiello Bowles, Brian L Sprague, Donald L Weaver, Anna N A Tosteson, Christoph I Lee

Journal of the American College of Radiology · 2025-08 · 22 (8) · 897-904

DOI: 10.1016/j.jacr.2025.04.008 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American College of Radiology, 2025-08. Verfasst von Louise M Henderson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Cancer Epidemiology Program Leader, UNC Lineberger …. Hauptthemen laut MEDLINE: Mammography, Breast Neoplasms, Critical Pathways. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Our objective was to assess the transition from digital mammography (DM) to digital breast tomosynthesis (DBT) screening, the authors compared diagnostic workup type and frequency, workup pathways, and time to resolution of abnormal screening between DBT and DM. METHODS: This cohort study included screening examinations with an abnormal results from 2011 to 2020 at 107 facilities across six Breast Cancer Surveillance Consortium registries. Diagnostic workup included diagnostic DM, diagnostic DBT, ultrasound, MRI, and biopsy within 90 days of the abnormal result on screening mammography. Workup modalities and number of workup procedures were compared using differences in proportion and 95% confidence intervals (CIs). Time to diagnostic resolution between DBT and DM was compared using a log-rank test. RESULTS: Among 77,123 DBT and 197,589 abnormal DM screening examinations with abnormal results, the number of imaging modalities in the diagnostic pathway was similar. The first workup procedure was more often ultrasound after abnormal results on DBT compared with DM (21.1% versus 4.7%). Biopsy rates were higher for DBT versus DM (16.2% versus 14.0%; difference in proportions = 2.27; 95% CI, 1.97-2.58) with biopsies after DM versus DBT more likely surgical versus fine-needle aspiration or core (5.8% versus 3.2%; difference in proportions = 2.6; 95% CI, 2.19-3.01), resulting in a rate of excision biopsy per 1,000 screens with abnormal findings of 5.1 for DBT and 8.0 for DM. Time to diagnostic resolution was similar (median, 10 days). CONCLUSIONS: This study revealed differences in the type of diagnostic workup pathways after abnormal results on screening DBT versus DM. Although the biopsy rate was higher after abnormal results on DBT, the biopsy type may be more invasive (surgical excision) after abnormal results on DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammographyBreast NeoplasmsCritical PathwaysHumansFemaleMiddle AgedAgedEarly Detection of CancerCohort StudiesRegistries

Stichwörter der Autor:innen

Care pathwaysdiagnostic workupdigital breast tomosynthesisdigital mammography

Autor:innen und Institutionen

  • Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Cancer Epidemiology Program Leader, UNC Lineberger Comprehensive Cancer Center. Electronic address: louise_henderson@med.…
  • Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
  • Department of Population Health Sciences, University of Utah, Salt Lake City, Utah Senior Director, Population Sciences, Huntsman Cancer Institute.
  • Departments of Medicine and Epidemiology and Biostatistics, University of San Francisco, California, San Francisco, California.
  • Department of Public Health Sciences, University of California, Davis, Davis, California; Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
  • Director of Collaborative Science, Kaiser Permanente Washington Health Research Institute, Seattle, Washington.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Cancer Institute

Zitieren

APA

Henderson, L. M., Zhu, W., Onega, T., Kerlikowske, K., Miglioretti, D. L., Aiello Bowles, E. J., Sprague, B. L., Weaver, D. L., Tosteson, A. N. A., & Lee, C. I. (2025). Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis. Journal of the American College of Radiology, 22(8), 897-904. https://doi.org/10.1016/j.jacr.2025.04.008

Vancouver

Henderson LM, Zhu W, Onega T, Kerlikowske K, Miglioretti DL, Aiello Bowles EJ, et al. Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis. Journal of the American College of Radiology. 2025;22(8):897-904. doi:10.1016/j.jacr.2025.04.008

BibTeX
@article{Henderson2025,
  author = {Henderson, Louise M and Zhu, Weiwei and Onega, Tracy and Kerlikowske, Karla and Miglioretti, Diana L and Aiello Bowles, Erin J and Sprague, Brian L and Weaver, Donald L and Tosteson, Anna N A and Lee, Christoph I},
  title = {Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis},
  journal = {Journal of the American College of Radiology},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {897--904},
  doi = {10.1016/j.jacr.2025.04.008}
}
Kostenlos starten →